Sientra to Participate in COVID-19 Webinar Panel Hosted by Maxim Group

Article Stock Quotes (1)

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 8/23/2026

1. WMT
2. ROST
3. AAP
4. SPY
5. NVDA

6. BABA
7. SPCX
8. AVGO
9. RMAX
10. HD

Get Alerts SIEN Hot Sheet

Price: $0.17 --0%

Overall Analyst Rating:
SELL (= Flat)

Join SI Premium – FREE

SANTA BARBARA, Calif., July 14, 2020 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics company, announced today that Jeff Nugent, President and Chief Executive Officer, will participate in a virtual webinar panel discussion hosted by Maxim Group and M-Vest on Thursday July 16th, 2020.The panel discussion, Beauty after the Beast – Aesthetics during COVID-19, is part of Maxim’s COVID-19 Virtual Conference Series: Re-Engaging Medical Practices in an Era of COVID-19.

Panel: Beauty after the Beast – Aesthetics during COVID-19Date: Thursday, July 16, 2020Time: 11:00 a.m. ET

To access the panel discussion, please RSVP HERE.

About Sientra

Headquartered in Santa Barbara, California, Sientra is a diversified global medical aesthetics company and a leading partner to aesthetic physicians. The Company offers a suite of products designed to make a difference in patients' lives by enhancing their body image, growing their self-esteem, and restoring their confidence. Sientra has developed a broad portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company’s Breast Products Segment includes its OPUS® breast implants, the first fifth generation breast implants approved by the FDA for sale in the United States, its ground-breaking Allox2® breast tissue expander with patented dual-port and integral drain technology, and BIOCORNEUM® the #1 performing, preferred and recommended scar gel of plastic surgeons(*). The Company’s miraDry Segment, comprised of its miraDry® system, is approved for sale in over 56 international markets and is the only non-surgical, FDA-cleared device indicated for the permanent reduction of underarm sweat and hair and may also reduce odor.

Sientra uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about Sientra is routinely posted and is accessible on the Company’s investor relations website at www.sientra.com.

(*) Data on file

ContactInvestor Relations805-679-8885